Management of Patients Diagnosed with Endometrial Hyperplasia: Comparison of Guidelines
Cancers · 24.06.2026 · 18 (13) · 2048
DOI: 10.3390/cancers18132048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 24.06.2026. Verfasst von Stefano Restaino und 30 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udi…. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometrial hyperplasia (EH) is an estrogen-driven proliferative disorder with a measurable risk of progression to endometrial carcinoma. Although many guidelines have been issued over the years, clinical practice remains heterogeneous. In this paper, we aim to compare and summarize key recommendations and disagreements among major international guidelines for managing endometrial hyperplasia, focusing especially on conservative and fertility-sparing strategies. All guidelines align with some key principles: they all adopt the 2020 WHO classification, strongly prefer hysteroscopy-directed sampling, and recommend progestin therapy as the first-line treatment for non-atypical EH, favoring the levonorgestrel-releasing intrauterine system (LNG-IUS) over oral regimens. They designate total hysterectomy as definitive management for atypical hyperplasia/intraepithelial endometrial neoplasia (AEH/EIN) due to the substantial prevalence of concurrent carcinoma. Nevertheless, several key discrepancies appear, mainly concerning how long to continue progestin therapy and when to escalate treatment; and how intensively and for how long to conduct post-treatment surveillance. Variations in diagnostic and therapeutic protocols reflect evidence gaps and differences across healthcare settings. Future research should focus on harmonized outcomes, comparative studies of conservative strategies, and the integration of new pathology tools for personalized management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy. stefano.restaino@asufc.sanita.fvg.it.
- PhD School in Biomedical Sciences, Gender Medicine, Child and Women Health, University of Sassari, 07100 Sassari, Italy. stefano.restaino@asufc.sanita.fvg.it.
- Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy. chiara.paglietti@asufc.sanita.fvg.it.
- Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy. federico.paparcura@asufc.sanita.fvg.it.
- Department of Medicine, University of Udine, 33100 Udine, Italy. federico.paparcura@asufc.sanita.fvg.it.
- Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy. giorgio.bogani@istitutotumori.mi.it.
Zitieren
APA
Restaino, S., Paglietti, C., Paparcura, F., Bogani, G., Capozzi, V. A., Catena, U., Raffone, A., Orsaria, M., Ronsini, C., Scibilia, G., Simoncini, T., Raimondo, D., Di Donato, V., Elhadi, M., Capobianco, G., Negre, R. R., Biasioli, A., Martina, M. D., Laura, M., …, & Collaborative Group (2026). Management of Patients Diagnosed with Endometrial Hyperplasia: Comparison of Guidelines. Cancers, 18(13), 2048. https://doi.org/10.3390/cancers18132048
Vancouver
Restaino S, Paglietti C, Paparcura F, Bogani G, Capozzi VA, Catena U, et al. Management of Patients Diagnosed with Endometrial Hyperplasia: Comparison of Guidelines. Cancers. 2026;18(13):2048. doi:10.3390/cancers18132048
BibTeX
@article{Restaino2026,
author = {Restaino, Stefano and Paglietti, Chiara and Paparcura, Federico and Bogani, Giorgio and Capozzi, Vito Andrea and Catena, Ursula and Raffone, Antonio and Orsaria, Maria and Ronsini, Carlo and Scibilia, Giuseppe and Simoncini, Tommaso and Raimondo, Diego and Di Donato, Violante and Elhadi, Muhammed and Capobianco, Giampiero and Negre, Ramon Rovira and Biasioli, Anna and Martina, Monica Della and Laura, Mariuzzi and Uccella, Stefano and Ciavattini, Andrea and Zupi, Errico and Seracchioli, Renato and Driul, Lorenza and Scollo, Paolo and Perrone, Anna Miryam and Iaco, Pierandrea De and Arcieri, Martina and Fanfani, Francesco and Vizzielli, Giuseppe and Collaborative Group, Collaborative Group},
title = {Management of Patients Diagnosed with Endometrial Hyperplasia: Comparison of Guidelines},
journal = {Cancers},
year = {2026},
volume = {18},
number = {13},
pages = {2048},
doi = {10.3390/cancers18132048}
}
EUVIMED